SCHEDULE: Morgan Stanley Cuts BiomX Stake Below 5%
Beneficial Ownership Change
Morgan Stanley and its subsidiary have reported ceasing to be beneficial owners of more than five percent of BiomX Inc.'s common stock.
Summary
- Morgan Stanley and Morgan Stanley & Co. LLC have filed an Amendment No. 1 to Schedule 13G for BiomX Inc.
- As of July 31, 2025, both Morgan Stanley and Morgan Stanley & Co. LLC ceased to be beneficial owners of more than five percent of BiomX Inc.'s common stock.
- The aggregate amount beneficially owned by each reporting person is 0.00 shares, representing 0.0% of the class of securities.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of BiomX Inc.
Sentiment
Score: 5
Explanation: The filing is administrative, reporting a change in beneficial ownership below a threshold. It does not contain positive or negative operational or financial news for the issuer, BiomX Inc.
Future Outlook
This administrative filing does not contain any forward-looking statements or guidance regarding BiomX Inc.'s future outlook.
Management Comments
- Christopher O'Hara, Authorized Signatory for Morgan Stanley and Morgan Stanley & Co. LLC, certified that the information set forth in the statement is true, complete, and correct.
Industry Context
This filing is an administrative disclosure by an institutional investor regarding a change in its passive ownership stake, rather than an announcement related to BiomX Inc.'s operational or strategic industry trends. It reflects a reduction in Morgan Stanley's investment below a reportable threshold.
Related Party Transactions
- Morgan Stanley & Co. LLC is a wholly-owned subsidiary of Morgan Stanley, and both entities are reporting jointly on their beneficial ownership.
Stakeholder Impact
- Shareholders: This filing indicates a reduction in a significant institutional investor's stake, which could be interpreted as a lack of conviction, but it is a passive filing and does not necessarily imply a negative view on the company's fundamentals.
Key Dates
| Date | Description |
|---|---|
| 07/31/2025 | Date of event which required the filing of this statement (Morgan Stanley's beneficial ownership dropped below 5%). |
| 08/07/2025 | Date of filing of this Schedule 13G Amendment No. 1. |
Keywords
BiomX Inc., Morgan Stanley, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Ownership Change
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.